Jessica Fung
Stock Analyst at JP Morgan
(0.47)
# 3,089
Out of 4,433 analysts
5
Total ratings
50%
Success rate
-14.53%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Neutral | $150 → $170 | $147.40 | +15.33% | 2 | Feb 1, 2024 | |
| UTHR United Therapeutics | Maintains: Overweight | $290 → $294 | $272.69 | +7.81% | 2 | Nov 2, 2023 | |
| FSM Fortuna Silver Mines | Upgrades: Outperform | n/a | $5.35 | - | 1 | Mar 31, 2017 |
Alnylam Pharmaceuticals
Feb 1, 2024
Maintains: Neutral
Price Target: $150 → $170
Current: $147.40
Upside: +15.33%
United Therapeutics
Nov 2, 2023
Maintains: Overweight
Price Target: $290 → $294
Current: $272.69
Upside: +7.81%
Fortuna Silver Mines
Mar 31, 2017
Upgrades: Outperform
Price Target: n/a
Current: $5.35
Upside: -